Citation Impact
Citing Papers
Improved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickase
2016 StandoutNobel
Effect of Recombinant α1-Antitrypsin Fc-Fused (AAT-Fc) Protein on the Inhibition of Inflammatory Cytokine Production and Streptozotocin-Induced Diabetes
2013
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
Re-theorising mobility and the formation of culture and language among the Corded Ware Culture in Europe
2017 Standout
Alpha-1-antitrypsin (AAT) anomalies are associated with lung disease due to rapidly growing mycobacteria and AAT inhibits Mycobacterium abscessus infection of macrophages
2007
α1-antitrypsin deficiency
2005
Susceptibility to Exacerbation in Chronic Obstructive Pulmonary Disease
2010 Standout
Cystic fibrosis
2016 Standout
COPD Guidelines: A Review of the 2018 GOLD Report
2018 Standout
Lipid nanoparticles for mRNA delivery
2021 Standout
Serpinopathies and the conformational dementias
2002
Integrated care prevents hospitalisations for exacerbations in COPD patients
2006 Standout
The Body-Mass Index, Airflow Obstruction, Dyspnea, and Exercise Capacity Index in Chronic Obstructive Pulmonary Disease
2004 Standout
Severe acute exacerbations and mortality in patients with chronic obstructive pulmonary disease
2005 Standout
Epidemiology of COPD
2009 Standout
British Thoracic Society guidelines for the management of non-tuberculous mycobacterial pulmonary disease (NTM-PD)
2017 Standout
Current and Future Burden of Chronic Nonmalignant Liver Disease
2015
Amniotic fluid stabilized lipid nanoparticles for in utero intra-amniotic mRNA delivery
2021 StandoutNobel
Irritable bowel syndrome
2016 Standout
Soluble triggering receptor expressed on myeloid cells-1 in acute respiratory infections
2006 Standout
Inflammaging and anti-inflammaging: A systemic perspective on aging and longevity emerged from studies in humans
2006 Standout
Alpha-1 antitrypsin deficiency and the risk of hepatocellular carcinoma in end-stage liver disease
2015
Clinical and Microbiologic Outcomes in Patients Receiving Treatment for Mycobacterium abscessus Pulmonary Disease
2011 Standout
Tuberculosis and lung damage: from epidemiology to pathophysiology
2018 StandoutNobel
Interpretative strategies for lung function tests
2005 Standout
Pulmonary-intestinal cross-talk in mucosal inflammatory disease
2011
Worldwide Racial and Ethnic Distribution of α1-Antitrypsin Deficiency
2002
Cystic fibrosis genetics: from molecular understanding to clinical application
2014 Standout
Gut microbiota and Covid-19- possible link and implications
2020 Standout
mRNA transcript therapy
2014 StandoutNobel
Alpha1-antitrypsin heterozygosity plays a positive role in attainment of longevity
2006
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
2004 Standout
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Genetic Modifiers of Liver Disease in Cystic Fibrosis
2009
Global burden of COPD: risk factors, prevalence, and future trends
2007 Standout
Clinical Practice Guidelines and Quality of Care for Older Patients With Multiple Comorbid Diseases
2005 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
A cross-sectional study of the prevalence and associations of iron deficiency in a cohort of patients with chronic obstructive pulmonary disease
2015 StandoutNobel
Protein Misfolding, Functional Amyloid, and Human Disease
2006 Standout
Pulmonary rehabilitation for chronic obstructive pulmonary disease
2015 Standout
SERPINA1 mRNA as a Treatment for Alpha-1 Antitrypsin Deficiency
2018
Ionizable lipid nanoparticles for in utero mRNA delivery
2021 StandoutNobel
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Physical Activity and Public Health in Older Adults
2007 Standout
Ultrasound Elastography: Review of Techniques and Clinical Applications
2017 Standout
[Value of computerized tomography in the diagnosis of complicated pneumoconiosis in coal miners].
1997
Neolithic and Bronze Age migration to Ireland and establishment of the insular Atlantic genome
2015
Works of Ignacio Blanco being referenced
Effect of one year of a gluten-free diet on the clinical evolution of irritable bowel syndrome plus fibromyalgia in patients with associated lymphocytic enteritis: a case-control study
2014
Genetic epidemiology of alpha‐1 antitrypsin deficiency in southern Europe: France, Italy, Portugal and Spain
2003
Estimated numbers and prevalence of PI*S and PI*Z alleles of α1-antitrypsin deficiency in European countries
2005
PI S and PI Z Alpha-1 antitrypsin deficiency worldwide. A review of existing genetic epidemiological data
2016
Genetic epidemiology of alpha‐1 antitrypsin deficiency in North America and Australia/New Zealand: Australia, Canada, New Zealand and the United States of America
2003
Alpha‐1‐antitrypsin PI phenotypes S and Z in Europe: an analysis of the published surveys
2001
Estimating the Risk for Alpha-1 Antitrypsin Deficiency among COPD Patients: Evidence Supporting Targeted Screening
2006
α 1-antitrypsin Pi phenotypes S and Z in Spain: an analysis of the published surveys
2001
Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema
2011
Distribution of α1‐antitrypsin PI S and PI Z frequencies in countries outside Europe: a meta‐analysis
2001
Aportaciones de la tomografía axial computarizada al estudio de la neumoconiosis de los mineros del carbón en estadios precoces
1993
Role of alpha‐1 antitrypsin in human health and disease
2014